120 related articles for article (PubMed ID: 38928260)
1. Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke.
Hervella P; Sampedro-Viana A; Fernández-Rodicio S; Rodríguez-Yáñez M; López-Dequidt I; Pumar JM; Mosqueira AJ; Bazarra-Barreiros M; Abengoza-Bello MT; Ortega-Espina S; Ouro A; Pérez-Mato M; Campos F; Sobrino T; Castillo J; Alonso-Alonso ML; Iglesias-Rey R
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928260
[TBL] [Abstract][Full Text] [Related]
2. The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation.
da Silva-Candal A; Pérez-Mato M; Rodríguez-Yáñez M; López-Dequidt I; Pumar JM; Ávila-Gómez P; Sobrino T; Campos F; Castillo J; Hervella P; Iglesias-Rey R
Ann Clin Transl Neurol; 2020 Nov; 7(11):2103-2114. PubMed ID: 33022893
[TBL] [Abstract][Full Text] [Related]
3. sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy.
da Silva-Candal A; Custodia A; López-Dequidt I; Rodríguez-Yáñez M; Alonso-Alonso ML; Ávila-Gómez P; Pumar JM; Castillo J; Sobrino T; Campos F; Iglesias-Rey R; Hervella P
Ann Clin Transl Neurol; 2022 Feb; 9(2):171-180. PubMed ID: 35060359
[TBL] [Abstract][Full Text] [Related]
4. Systemic biomarker associated with poor outcome after futile reperfusion.
Hervella P; Sampedro-Viana A; Rodríguez-Yáñez M; López-Dequidt I; Pumar JM; Mosqueira AJ; Fernández-Rodicio S; Bazarra-Barreiros M; Serena J; Silva-Blas Y; Gubern-Merida C; Rey-Aldana D; Cinza S; Campos F; Sobrino T; Castillo J; Alonso-Alonso ML; Iglesias-Rey R
Eur J Clin Invest; 2024 Jun; 54(6):e14181. PubMed ID: 38361320
[TBL] [Abstract][Full Text] [Related]
5. Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels.
Campos F; Rodríguez-Yáñez M; Castellanos M; Arias S; Pérez-Mato M; Sobrino T; Blanco M; Serena J; Castillo J
Clin Sci (Lond); 2011 Jul; 121(1):11-7. PubMed ID: 21265738
[TBL] [Abstract][Full Text] [Related]
6. High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke.
Campos F; Sobrino T; Ramos-Cabrer P; Castellanos M; Blanco M; Rodríguez-Yáñez M; Serena J; Leira R; Castillo J
J Cereb Blood Flow Metab; 2011 Jun; 31(6):1387-93. PubMed ID: 21266984
[TBL] [Abstract][Full Text] [Related]
7. The Smoking Paradox in Stroke Patients Under Reperfusion Treatment Is Associated With Endothelial Dysfunction.
Iglesias-Rey R; Custodia A; Alonso-Alonso ML; López-Dequidt I; Rodríguez-Yáñez M; Pumar JM; Castillo J; Sobrino T; Campos F; da Silva-Candal A; Hervella P
Front Neurol; 2022; 13():841484. PubMed ID: 35401421
[TBL] [Abstract][Full Text] [Related]
8. Clinical validation of blood/brain glutamate grabbing in acute ischemic stroke.
da Silva-Candal A; Pérez-Díaz A; Santamaría M; Correa-Paz C; Rodríguez-Yáñez M; Ardá A; Pérez-Mato M; Iglesias-Rey R; Brea J; Azuaje J; Sotelo E; Sobrino T; Loza MI; Castillo J; Campos F
Ann Neurol; 2018 Aug; 84(2):260-273. PubMed ID: 30014516
[TBL] [Abstract][Full Text] [Related]
9. The Diagnostic Value of sTWEAK in Acute Ischemic Stroke.
Comertpay E; Vural S; Eroğlu O; Dindar Badem N; Karadeniz Bilgili Y; Coşkun F
Balkan Med J; 2020 Oct; 37(6):336-340. PubMed ID: 32856885
[TBL] [Abstract][Full Text] [Related]
10. sTWEAK is a marker of early haematoma growth and leukoaraiosis in intracerebral haemorrhage.
da Silva-Candal A; López-Dequidt I; Rodriguez-Yañez M; Ávila-Gómez P; Pumar JM; Castillo J; Sobrino T; Campos F; Iglesias-Rey R; Hervella P
Stroke Vasc Neurol; 2021 Dec; 6(4):528-535. PubMed ID: 33758070
[TBL] [Abstract][Full Text] [Related]
11. Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients.
Fan WC; Huang CC; Yang YY; Lin A; Lee KC; Hsieh YC; Fung CP; Hsu HC; Hou MC; Lin HC
J Microbiol Immunol Infect; 2017 Dec; 50(6):905-914. PubMed ID: 26872435
[TBL] [Abstract][Full Text] [Related]
12. sTWEAK as Predictor of Stroke Recurrence in Ischemic Stroke Patients Treated With Reperfusion Therapies.
Hervella P; Pérez-Mato M; Rodríguez-Yáñez M; López-Dequidt I; Pumar JM; Sobrino T; Campos F; Castillo J; da Silva-Candal A; Iglesias-Rey R
Front Neurol; 2021; 12():652867. PubMed ID: 34046003
[No Abstract] [Full Text] [Related]
13. Glutamate oxaloacetate transaminase: a new key in the dysregulation of glutamate in migraine patients.
Campos F; Sobrino T; Pérez-Mato M; Rodríguez-Osorio X; Leira R; Blanco M; Mirelman D; Castillo J
Cephalalgia; 2013 Oct; 33(14):1148-54. PubMed ID: 23674828
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study.
Campos F; Sobrino T; Ramos-Cabrer P; Argibay B; Agulla J; Pérez-Mato M; Rodríguez-González R; Brea D; Castillo J
J Cereb Blood Flow Metab; 2011 Jun; 31(6):1378-86. PubMed ID: 21266983
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble TWEAK levels in severe traumatic brain injury and its prognostic significance.
Tang B; Zhong Z; Qiu Z; Wu HP; Hu JY; Ma JP; Wu JP
Clin Chim Acta; 2019 Aug; 495():227-232. PubMed ID: 31009601
[TBL] [Abstract][Full Text] [Related]
16. Potential protective role of endogenous glutamate-oxaloacetate transaminase against glutamate excitotoxicity in fetal hypoxic-ischaemic asphyxia.
Pérez-Mato M; Iglesias-Deus A; Rujido S; da Silva-Candal A; Sobrino T; Couce ML; Fraga JM; Castillo J; Campos F
Dev Med Child Neurol; 2016 Jan; 58(1):57-62. PubMed ID: 26205194
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of soluble TNF-like weak inducer of apoptosis (sTWEAK) levels to predict preeclampsia in early weeks of pregnancy.
Shahid S; Khalid E; Fatima SS; Khan GM
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():165-170. PubMed ID: 30708268
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of serum interleukin-8 and soluble tumor necrosis factor-like weak inducer of apoptosis levels in patients with diabetic nephropathy.
Liu SY; Chen J; Li YF
J Diabetes Investig; 2018 Sep; 9(5):1182-1188. PubMed ID: 29489069
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of glutamate during stroke is associated with development of post-stroke depression.
Cheng SY; Zhao YD; Li J; Chen XY; Wang RD; Zeng JW
Psychoneuroendocrinology; 2014 Sep; 47():126-35. PubMed ID: 25001962
[TBL] [Abstract][Full Text] [Related]
20. Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease.
Fernández-Laso V; Méndez-Barbero N; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
Atherosclerosis; 2017 May; 260():130-137. PubMed ID: 28390291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
